SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech for less than cash value

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RWReeves who started this subject9/23/2002 4:52:07 PM
From: nigel bates  Read Replies (1) of 684
 
I think we're all a bit behind on a full listing of sub (net)cash stocks for the thread.
Here's another one - VICL - (current cap c.$80m) ...

                                           June 30,        December 31,
2002 2001
(Unaudited)
Assets:
Cash and cash equivalents $14,745 $43,736
Marketable securities 108,576 90,351
Other current assets 4,472 4,636
Total current assets 127,793 138,723
Investment, at cost 5,000 5,000
Property and equipment, net 5,206 5,060
Other assets 5,999 5,712
$143,998 $154,495
Liabilities and Stockholders' Equity:
Current liabilities $7,991 $7,790
Long-term obligations 4,146 4,546
Stockholders' equity 131,861 142,159



Their current clinical trials may well be a waste of time & cash, but there's always the possibility of a decent royalty on the AIDS vaccine (& other stuff).

nig
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext